A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.

Zimbabwe to administer the long‑acting HIV prevention drug Lenacapavir to at least 46,500 people early next year, a senior ...

Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option ...

Zimbabwe is preparing to place at least 46 500 people on a long-acting HIV prevention drug early next year marking the ...

Compounding that statistic, prior studies indicate some trans people at high risk for HIV transmission are hesitant to take ...

It comes after an injection to prevent HIV, called cabotegravir (CAB-LA) injections, is to be offered to patients on the NHS ...

The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that causes AIDS. The injectable drug lenacapavir was approved in June and is ...

Key PointsResearch on HIV's conical capsid that began over 25 years ago led to the development of lenacapavir, the world's ...

Common HIV and cancer medications damage brain cell functions (lipid imbalance), contributing to cognitive decline. Need for ...

Malawi Greenlights Injectable HIV Prevention Drug. Malawi has become the fourth African country to greenlight lenacapavir, a breakthrough injectable HIV prevention medication, following an accelerated ...

The Trump administration's funding cuts to PEPFAR and USAID disrupted global HIV treatment and prevention, threatening progress made over decades. Lenacapavir's FDA approval as a long-acting ...

South Africa, Eswatini and Zambia in December began administering a groundbreaking HIV-prevention injection in the drug's first public rollouts in Africa, which has the world's highest HIV burden.